Skip Navigation

Yepes Laboratory People

Manuel Yepes, MD

myepes@emory.edu
Manuel Yepes is a board certified Neurologist and Vascular Neurologist trained in Georgetown University in Washington D.C. where he was elected to the Alpha Omega Alpha Honor Medical Society.  He is a Professor of Neurology in Emory University and Director of the Stroke Center at the VAMC in Atlanta, GA.  He also received post-doctoral training in Vascular Biology at the Holland Laboratory of the American Red Cross/George Washington University, Rockville, MD & Washington D.C.  As a clinician, Dr. Yepes is actively involved in the diagnostic and treatment of stroke patients.  As a scientist, he is the director of the laboratory of Cerebrovascular Neurosciences in the Center for Neurodegenerative Diseases in Emory University.  Dr. Yepes is fellow of the American Neurological Association, American Academy of Neurology, American Heart Association and Society for Neurosciences.

Click here for publications list.

Dr Yepes

Fang Wu, PhD

fwu3@emory.edu
Fang Wu received her PhD degree from University of Science and Technology (USTC) in China in 2004. She joined the Department of Pharmacology at Emory University as post-doctoral fellow to study signaling pathways associated with neurodegenerative diseases. In 2010 she joined the Yepes laboratory to study the molecular mechanisms underlying the neuroprotective effect of tissue-type plasminogen activator in the ischemic brain.

Wu

Enrique Torre, PhD

etorre@emory.edu
Enrique Torre received a PhD degree in chemistry from the Instituto de Investigación Médica MM Ferreira/Universidad Nacional de Córdoba, in Argentina in 1986.  His research focuses on the role of tissue-type plasminogen activator in the development of synaptic plasticity under physiological and pathological conditions such as cerebral ischemia. 

Torre

Lihong Cheng, MD

lihong.cheng@emory.edu
Dr. Cheng is a physician from Hunan medical school in China with extensive expertise in small animal surgery and molecular biology.  Dr. Chen studies the effects of urokinase-type plasmnogen activator in the ischemic brain.

Cheng